Dr. James M. Anderson has been named director
of NIH’s Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI, known affectionately on campus as ‘D-Poughkeepsie’)
and is due to arrive this month.
“With experience in clinical medicine,
research and in administration, Dr. Anderson has a broad understanding
of the biomedical
research spectrum that will serve him and the NIH well as he works with us to evaluate, prioritize and coordinate a wide range of trans-NIH research opportunities,”
said NIH director Dr. Francis Collins. “I am thrilled to have recruited him to NIH.”
DPCPSI’s mission includes identifying emerging
scientific opportunities, rising public health challenges and scientific knowledge gaps that merit further research. It plans and implements trans-NIH initiatives supported by the Common
Fund and coordinates research related to AIDS, behavioral and social sciences, women’s health and disease prevention.
Anderson was most recently professor and chair of the department of cell and molecular physiology
in the School of Medicine at the University
of North Carolina at Chapel Hill, a position he held since 2002. Before his appointment at UNC, he was professor of medicine and cell biology
and chief, section of digestive diseases, Yale School of Medicine.
Anderson has extensive clinical experience in both internal medicine and hepatology. He is considered among the top authorities in the world in his primary research field of tight junctions
and paracellular transport. He has been a principal investigator on NIH grants for almost 20 years.
The Common Fund encourages collaboration and supports a series of high-impact, trans-NIH programs. The programs are managed by the NIH Office of the Director in partnership with the institutes and centers.